Related Experiment Video
Updated: Jun 25, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Blunted heart rate response during dipyridamole stress SPECT is associated with cardiovascular outcomes in an
Alexander Izhaki1, Aviram Akuka2,3, Alexey Migranov1
1Heart Institute, Edith Wolfson Medical Center, 62 Halochamim Street, Holon, 5810001, Israel.
Insights
Blunted heart rate response (BHRR) during dipyridamole stress cardiac 99mTc-SPECT (DS-SPECT) is linked to increased cardiovascular death. Combining BHRR with abnormal DS-SPECT imaging further elevates risks for cardiovascular morbidity and all-cause mortality.
Area of Science:
- Cardiology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Dipyridamole stress cardiac 99mTc-SPECT (DS-SPECT) is a standard tool for diagnosing myocardial ischemia.
- Blunted heart rate response (BHRR) during pharmacologic stress is a potential indicator of adverse cardiovascular outcomes.
- The clinical significance of BHRR in unselected real-world DS-SPECT cohorts remains to be fully elucidated.
Purpose of the Study:
- To evaluate the prognostic significance of BHRR in patients undergoing DS-SPECT.
- To compare the predictive value of BHRR with conventional DS-SPECT imaging findings.
- To assess the combined impact of BHRR and abnormal imaging on cardiovascular outcomes.
Main Methods:
- A retrospective cohort study included adult patients who underwent DS-SPECT between 2014 and 2017.
- Clinical data were extracted from electronic medical records and pre-test interviews.
- Patients were followed up for cardiovascular events and mortality through September 2020.
Main Results:
- The study included 388 patients; 63.1% exhibited BHRR.
- BHRR was independently associated with an 8-fold increased risk of cardiovascular death (HR 8.09, p<0.05).
- Patients with both abnormal DS-SPECT imaging and BHRR had a nearly fourfold increased risk of adverse cardiovascular events (HR 3.79, p<0.05) and the highest all-cause mortality (HR 2.93, p<0.01).
Conclusions:
- BHRR in patients undergoing DS-SPECT is significantly associated with cardiovascular mortality.
- The combination of BHRR and abnormal DS-SPECT findings substantially increases the risk of cardiovascular morbidity and all-cause mortality.
- BHRR should be considered as a valuable prognostic marker in DS-SPECT assessments.
Background:
Dipyridamole stress cardiac 99mTc-SPECT (DS-SPECT) is commonly used to detect myocardial ischemia. Blunted heart rate response (BHRR) during pharmacologic stress has been associated with adverse outcomes. This study evaluated the significance of BHRR in an unselected real-world DS-SPECT cohort and compared it with routine imaging findings.
Methods:
In this single-center retrospective cohort study, all adult patients who underwent dipyridamole stress SPECT without adjunct exercise between 2014 and 2017 were included. Clinical data were obtained from the electronic medical record and structured pre-test interviews, and patients were followed through September 2020.
Results:
Study population consisted of 388 patients, 227 (58.5%) had normal imaging results, and 245 (63.1%) exhibited BHRR. During a mean follow-up of four years, multivariable analysis found association of BHRR with cardiovascular death (HR 8.09, 95% CI:1.06-61.91, p < 0.05). Patients with abnormal DS-SPECT imaging and BHRR had a nearly fourfold increased risk of adverse cardiovascular events (HR 3.79, 95% CI: 1.24-11.63, p < 0.05). Moreover, individuals demonstrating both abnormal imaging results and BHRR experienced the highest rate of all-cause mortality (HR 2.93, 95% CI: 1.1-7.7, p < 0.01). Overall, BHRR significantly correlated with increased all-cause and cardiovascular mortality.
Conclusions:
In unselected patients referred to DS-SPECT, BHRR was associated with cardiovascular mortality. Moreover, in our population group, when combined with abnormal imaging results, BHRR significantly increases the association with DS-SPECT for cardiovascular morbidity and all-cause mortality. These findings may support future inclusion of BHRR in DS-SPECT studies.
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Heart Failure Drugs: β-Blockers